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Abstract
Background—The number of HIV-infected women giving birth in the U.S. is increasing.
Research on pregnancy planning in HIV-infected women is limited.
Methods—Between January 1 and December 30, 2012, pregnant women with a known HIV
diagnosis prior to conception at 12 U.S. urban medical centers completed a survey including the
London Measure of Unplanned Pregnancy (LMUP) scale. We assessed predictors of LMUP
category (unplanned/ambivalent versus planned pregnancy) using bivariate and multivariable
analyses.
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Results—Overall, 172 women met inclusion criteria and completed a survey. Based on self-
report using the LMUP scale, 23% of women had an unplanned pregnancy, 58% were ambivalent
and 19% reported a planned pregnancy. Women were at lower risk for an unplanned or ambivalent
pregnancy if they had previously given birth since their HIV diagnosis (adjusted Relative Risk =
0.67, 95% CI 0.47-0.94, p=0.02), had seen a medical provider in the year before the index
pregnancy (aRR 0.60, 95% CI 0.46-0.77, p<0.01), or had a patient-initiated discussion of
pregnancy intentions in the year prior to the index pregnancy (aRR = 0.63, 95% CI 0.46-0.77,
p<0.01). Unplanned or ambivalent pregnancy was not associated with age, race/ethnicity, or
educational level.
Conclusions—In this multi-site U.S. cohort, patient-initiated pregnancy counseling as well as
being engaged in medical care prior to pregnancy were associated with a decreased probability of
unplanned or ambivalent pregnancy. Interventions that promote health-care engagement among
HIV-infected women and integrate contraception and preconception counseling into routine HIV
care may decrease the risk of unplanned pregnancy among HIV-infected women in the U.S.
Keywords
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Background
There are approximately 280,000 HIV-infected women in the U.S. and an estimated 140,000
serodifferent couples (in which only one member of the partnership has HIV) living in the
U.S. 1,2 The number of HIV-infected women giving birth in the U.S. increased by
approximately 30% between 2000 to 2006.3 Research on pregnancy intention in HIV-
infected women is limited.4-6 To address prevention of sexual HIV transmission, a family
planning discussion may focus on condoms in order to prevent both pregnancy and HIV/
sexually transmitted infection (STI) transmission. Though condoms decrease the risk of STI
transmission, they are only 83% effective in preventing pregnancy 7 and counterproductive
for couples who desire pregnancy.8 Hence, prevention of HIV transmission through
condoms and a woman's desire for pregnancy are in clear conflict. Additionally, recent
research indicates that antiretroviral (ARV) use by an HIV-infected partner reduces HIV
transmission risk by 96% in serodifferent heterosexual couples.9 Preexposure prophylaxis
(PrEP) has been shown to reduce HIV transmission by 62-73%; a 90% reduction is reported
with confirmed adherence to PrEP. 10,11 With improved options for safe conception and risk
of perinatal HIV transmission potentially at less than 1% for women with undetectable viral
load at delivery, there is now greater opportunity for providers and patients to engage in
patient-centered conversations on how HIV-infected women can both achieve pregnancy
safely and avoid perinatal HIV transmission.1,12,13 Given the limited data on pregnancy
intentions among HIV-infected women in the US, we sought to assess pregnancy intentions
and factors associated with unplanned pregnancies in this multi-site cohort of HIV-infected
pregnant women in the United States.
Methods
Study population and recruitment
The HIV and Obstetrics Pregnancy Education Study (HOPES) was a multi-site cross-
sectional study of HIV-infected pregnant women presenting to obstetric or HIV-related care
from Jan 1, 2012 to Dec 31, 2012. Each study site participated for a total of 6-months within
the allotted study time period. A request for participation was enlisted on the University of
California San Francisco-Infectious Disease Society for Obstetrics and Gynecology
Reproductive Infectious Disease listserv. Researchers from 12 academic medical centers
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agreed to collaborate. Institutional Review Board approval or exemption was completed at
each of the 12 sites.
Study personnel at each site consecutively approached HIV-infected pregnant women who
were 18 years or older, able to read English or Spanish and whose HIV infection status was
known prior to the current pregnancy. Participating women completed the anonymous study
survey and placed it in a pre-stamped and addressed envelope which was directly mailed to
the coordinating site. Participants received $10 gift cards for completion of the survey. All
sites returned a study log listing the number of HIV-infected women treated in their clinic
during the 6 month interval as well as non-identifying descriptive data such as the time of
HIV diagnosis (prior to pregnancy or during current pregnancy) and preferred language.
Survey
The study survey included the London Measure of Unplanned Pregnancy (LMUP), a
psychometrically validated index of pregnancy intentions designed to be used in women
who are already pregnant. The LMUP has been validated in English and Spanish in low
literacy settings. 14,15 The survey also assessed respondents' socio-demographic and clinical
characteristics including age, race/ethnicity, education, parity, parity since HIV diagnosis,
relationship with the biological father, awareness of HIV status of the biological father,
disclosure of participant HIV status to biological father, having seen a health care provider
or having discussed pregnancy intention, contraception or condom use prior to pregnancy,
and ARV use in the year prior to pregnancy.
Analysis
Respondents' socio-demographic and clinical characteristics, listed in Table 1, were
described using medians and ranges and frequencies. Due to survey questions left
unanswered, missing data was acknowledged by description of denominator for all
frequencies. LMUP scores (0-12) were initially categorized according to criteria put forth by
Geraldine Barrett and colleagues. 14 Scores 0-3 represent an unplanned pregnancy, 4-9 an
ambivalent pregnancy, and 10-12 a planned (or highly planned) pregnancy. 14 After
examining the distribution of scores in our sample, scores were transformed into a
dichotomous variable with levels “unplanned/ambivalent pregnancy” and “planned
pregnancy” to facilitate the identification of characteristics associated with pregnancies that
were not fully planned.
Bivariate and multivariable-adjusted relative risks between patient characteristics and the
dichotomous pregnancy intention outcome (unplanned/ambivalent pregnancy vs. planned
pregnancy) were estimated using log-linear statistical models. All multi-level categorical
variables were collapsed into clinically meaningful dichotomous variables prior to being
entered into the models. In consideration of the modest sample size, only demographic
characteristics and variables with a statistically significant bivariate association of p<0.05
were included in the multivariable model. Crude and adjusted RRs were estimated using the
modified Poisson method, which allows for estimation of robust error variance for
dichotomous outcomes.16 All analyses were conducted using SAS version 9.2 (Cary, North
Carolina).
Results
Between Jan 1, 2012 to December 31, 2012, 324 HIV-infected women received prenatal
care at 12 tertiary care medical centers based on a composite of the study logs from each
site. Of these, 243 met study inclusion criteria - 67 women were excluded because they were
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diagnosed in the index pregnancy and 14 could not read English or Spanish. We received
surveys from 71% (172/243) of eligible participants.
Approximately one-third (37%, 63/172) of participants reported that they were diagnosed
with HIV during a previous pregnancy. The median age at HIV diagnosis was 22 years
(range 0-34). The median age of respondents at time of survey completion was 28 years
(range 18-42) with the majority of women self-identifying as Black, parous and having
received high school education or beyond. (Table 1)
Most (77%, 132/171) of the participants reported having only one sexual partner in the last
year (range 1-6). Nearly all participants (92%, 156/169) were able to identify the biological
father and only about one-third (31%, 45/143) of those identified partners were reportedly
also HIV-infected. The majority (74%, 124/167) of women reported disclosure of HIV
serostatus to all of their sexual partners. (Table 1)
Participants were asked about health care utilization in the year prior to the index pregnancy.
The majority (86%, 149/172) of women reported that they had seen medical providers in the
year prior to pregnancy, including a primary care provider (34%, 59/172), HIV specialist
(77%, 132/172) or obstetrician/gynecologist (29%, 49/172). About half of the respondents
who saw a provider reported seeing multiple providers (47%, 70/149). Forty-four of the 49
women who saw an obstetrician/gynecologist also saw and HIV provider. Most women
reported ARV therapy in the year prior to pregnancy (81%, 127/156). Approximately half
(45%, 70/154) of participants had initiated a conversation with their provider about interest
in pregnancy, and 60% (93/154) of women reported that a health care provider had talked to
them about their interest in pregnancy. The majority of women reported that a health care
provider had talked to them about contraception/birth control (81%, 127/156) or condom use
(97%, 152/157) to prevent HIV/STI transmission. (Table 1)
London Measure of Unplanned Pregnancy Scoring
Using the standardized LMUP scoring rubric, 23% of women had an unplanned pregnancy,
58% were ambivalent and 19% reported a planned pregnancy. Responses to each of the six
questions comprising the LMUP survey are found in Table 2. Most (68%) women were
using no or inconsistent contraception in the month they became pregnant. About half (48%)
acknowledged that their pregnancy had occurred at not quite the right time and about half
(52%) felt that they had not intended to get pregnant. In fact, 54% stated that just before they
became pregnant they did not want to have a baby. Only 36% reported that both members of
the couple discussed and agreed on the pregnancy prior to this index pregnancy. Lastly, 36%
percent of respondents did not specifically prepare for the pregnancy such as seeking
medical advice, taking prenatal vitamins, promoting healthy habits or decreasing substance
use.
In bivariate analysis, having had one or more births since HIV diagnosis (RR 0.81, 95% CI,
0.75-0.87,p<0.01), having had a provider-initiated discussion about pregnancy intentions
(RR 0.85, 95% CI, 0.73-1.00, p=0.05), having had a patient-initiated discussion about
pregnancy intentions (RR 0.70 95% CI, 0.59-0.83, p<0.01), having seen a medical provider
in the year prior to pregnancy (RR 0.81 95% CI, 0.72-0.92, p<0.01), having disclosed their
HIV status to their male partner (RR 0.78 95% CI, 0.71-0.86, p<0.01) or knowing the
identity of the biological father (RR 0.79 95% CI, 0.73-0.86, p<0.01) were all associated
with a lower risk of having an unplanned/ambivalent index pregnancy. (Table 3) In a logistic
regression model controlling for age, race and all independent variables with significant
bivariate associations, births since HIV diagnosis(aRR 0.67, 95% CI, 0.47-0.94,p=0.02),
having seen a health care provider (aRR 0.60, 95% CI, 0.46-0.77,p<0.01) and having a
patient-initiated pregnancy discussion (aRR 0.63, 95% CI, 0.46-0.77,p<0.01) in the year
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prior to pregnancy remained associated with a decreased risk of unplanned or ambivalent
pregnancy. (Table 3)
Discussion
In this US-based, multicenter, cross-sectional study, we found that the majority of
pregnancies among HIV-infected women were unplanned or ambivalent. Access to medical
care and discussion of fertility intentions were associated with a decreased risk of an
unplanned/ambivalent pregnancy.
A strength of this study is that it included participants from several sites across the U.S.. The
generalizability of these data are limited given only academic medical centers and sites with
clinician-investigators with special interests in HIV and pregnancy were included.
Therefore, findings from this study may be biased towards planning pregnancies and
discussion of pregnancy intentions compared to the HIV-infected population as a whole.
Additionally, though our study sites were across the U.S., most participants were from the
southern part of the U.S. and most participants self-described as non-Hispanic Black.
However, this may be a strength of the study as the numbers of HIV infections in Black
women are rising, particularly in the southern U.S.17 Previous research also indicates that
Black women, in general, are disproportionately affected by unplanned pregnancy compared
to other racial groups.18,19
A potential limitation of this study is social desirability bias. Women who are already
pregnant may not recall or wish to recall any negative feelings they may have had regarding
the index pregnancy. In order to diminish this bias, we used the validated LMUP scale
which is specifically designed to assess pregnancy intentions retrospectively. Another
potential limitation of this observational study could be unexpected and unmeasured
predictors of pregnancy intention. Given the small sample size, we may have lacked power
to definitively rule out certain associations with unplanned or ambivalent pregnancies.
This study supports previously published research describing limited discussion of
preconception issues by HIV care providers based on reports from HIV-infected women in
the U.S.20-22 A survey of 181 women attending an HIV clinic in Baltimore demonstrated
that only 67% of women had a general discussion about pregnancy; 31% had a personalized
discussion, and the majority of all discussions were patient-initiated.4 A comparison study
between practices in the U.S. and Brazil also demonstrated lack of communication on the
part of providers regarding pregnancy intentions in both locations.21 A strength of our study
is that we report a modifiable variable associated with unplanned/ambivalent pregnancy and
that this finding should motivate providers to discuss these topics.
Our study showed that having had a prior birth since HIV diagnosis was associated with a
decreased risk unplanned pregnancy. We can speculate that this may be related to increased
knowledge regarding low risk of transmission of HIV during pregnancy from past
experience and, therefore, less ambivalence or fear regarding planning for a future
pregnancy. Indeed, though the risk of perinatal HIV transmission is low, there is still
significant stigma that women perceive related to child bearing, including fears of negative
consequences towards themselves or their children related to HIV serostatus disclosure.23-25
A survey of 700 HIV-infected women geographically distributed across the U.S. reported
that only 57% of the 159 pregnant women had a discussion regarding appropriate HIV
treatment regimens prior to conception.23 Of the total women surveyed, 59% believed that
society urged them not to have children.23
Data reported in our study also supports previous research described from a Houston
prenatal care clinic in which 34% of HIV-infected pregnant women did not know the HIV
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status of their partner and 40% reported that their partner was HIV-uninfected.26 In our
study, 46% of the participants did not know the HIV-status of their male partner and 28%
presumed their partners were HIV-uninfected. Most women reported disclosure of HIV
status to their partners, but 26% of participants reported that some or none other their
partners knew their HIV status. Although we do not know whether women in this cohort
employed safer sex practices to conceive, it appears that a significant proportion of women
were in serodifferent relationships with potential for sexual HIV transmission. Screening
and prevention education for uninfected male partners is also integral to preconception
counseling of HIV-infected women.
Our findings suggest that family planning - including discussions of effective contraception,
pregnancy intentions and safer conception methods – alongside with HIV prevention
education - is needed in this population both postpartum and in the primary HIV care
setting. Enhanced screening for HIV to diagnose individuals with unknown serostatus and
then maintaining all HIV-infected individuals on ARVs, if clinically indicated, are also key
prevention measures.9 This type of comprehensive care can be achieved through a
multidisciplinary (infectious disease, obstetrics and gynecology, primary care, social work,
nursing) awareness of the unique health needs of women with HIV. In our study,
respondents were commonly seen by multiple types of providers (e.g. primary care, HIV
specialist, obstetrics/gynecology) in the year prior to pregnancy, limiting our ability to
determine which provider types were most likely to deliver family planning and prevention
messages. Future studies further elucidating patient-provider communication of family
planning and prevention messages could help inform this multidisciplinary delivery of care.
Based on data from this U.S. cohort, discussion of pregnancy intentions with a health care
provider was associated with a decreased risk of unplanned or ambivalent pregnancy. Given
HIV is a chronic medical illness requiring preconception management and there are risks of
sexual and perinatal HIV transmission during conception and pregnancy, our goal should be
to maximize the number of planned pregnancies. Our data also suggest that a significant
number of women in serodifferent relationships are conceiving without knowledge of their
partner's HIV serostatus and may need additional advice to promote safer conception.
Outcomes related to unintended pregnancy are similar to HIV transmission: increased risk of
morbidity and mortality, adverse health outcomes for children, and poor family health.27,28
Organizations such as the Centers for Disease Control and Prevention (CDC) and Infectious
Diseases Society of America (IDSA) already endorse discussion of pregnancy intentions and
contraception as part of primary medical care of HIV-infected women.29 Interventions that
increase the provision of preconception counseling and ART use may increase the likelihood
of planned pregnancy among HIV-infected women in the US and promote options to
decrease risk of HIV transmission among serodifferent couples.
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Table 1
Characteristics of HIV-infected pregnant women (N=172)*
BACKGROUND N (%)
Median age (range) in years 28 (18-42)
Median age at HIV diagnosis (range) in years 22 (0-34)
Setting of HIV diagnosis, N=170
 Past pregnancy 63 (37)
 Outside of pregnancy 109 (63)
Race/ethnicity
 Non Hispanic Black 135 (78)
 Non Hispanic White 15 (9)
 Other 22 (13)
Education – highest level completed, N=170
 Less than high school 11 (6)
 High School 72 (42)
 Some college or technical school 59 (35)
 College or more 28 (17)
One or more prior births, N=171 131 (77)
One or more births since HIV diagnosis 104 (60)
PARTNER ISSUES
Sexual partners in last year, N=171
 Median 1 (1-6)
 1 132 (77)
 2 or more 39 (23)
Known biological father 156 (92)
Reported HIV serostatus of biological father, N=143
 HIV-infected 45 (31)
 HIV-negative 79 (55)
 Unknown 19 (13)
Disclosure of HIV infection to sexual partner(s) in last year, N=167
 Disclosure to all partner(s) 124 (74)
 Disclosure to some partner(s) 27 (16)
 Disclosure to no partner(s) 16 (10)
HEALTH CARE
Health care in year prior to pregnancy, N=172, ** 149 (87)
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BACKGROUND N (%)
 HIV-specialist 132 (77)
 Obstetrician/Gynecologist 49 (29)
 Primary Care 59 (34)
Antiretroviral medication in year prior to pregnancy, N=156 127 (81)
Discussion of fertility intentions with health provider, N=154**
 Patient-initiated 70 (45)
 Provider-initiated 93 (60)
Provider-initiated discussion regarding condom use, N=157 152 (97)
Provider-initiated discussion regarding contraception, N=156 127 (81)
*
Denominators may vary based on response completion; results represent N (%) unless otherwise specified
**
More than one response possible; 70 women saw multiple providers
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Table 2
London Measure of Unplanned Pregnancy (LMUP)* among HIV-infected, Pregnant
Women in the United States. (N=172)**
%
In the month that I became pregnant… (N=170)
I/we were not using contraception at all 88 (52)
I/we were using contraception, but not every time we had sex 27 (16)
I/we always used contraception, but knew that the method had failed at least once 38 (22)
I/we always used contraception (birth control) 17 (10)
In terms of becoming a mother, I feel that my current pregnancy happened at the…
right time 66 (38)
ok, but not quite right time 83 (48)
wrong time 23 (13)
Just before I became pregnant this time…
I intended to get pregnant 41 (24)
my intentions kept changing 42 (24)
I did not intend to get pregnant 89 (52)
Just before I became pregnant this time… (N=171)
I wanted to have a baby 64 (37)
I had mixed feelings about having a baby 66 (39)
I did not want to have a baby 41 (24)
Before I became pregnant…. (N=169)
My partner and I had agreed that we would like me to be pregnant 61 (36)
My partner and I had discussed having children together, but had not agreed for me to get pregnant 66 (39)
We never discussed having children together 42 (25)
Before you became pregnant, did you do anything in preparation for pregnancy?***
took folic acid or prenatal vitamins 22 (13)
stopped or cut down smoking 14 (8)
stopped or cut down drinking alcohol or using drugs 14 (8)
ate more healthily 21 (12)
got medical/health advice 30 (17)
did something else to prepare 2 (<1)
 -or---
I did not do any of the above before my pregnancy 110 (64)
*
Questions listed in table are abbreviated from full LMUP survey administered.
**
Denominators may vary based on response completion.
***
More than one response possible
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Table 3
Predictors of Unplanned/Ambivalent Pregnancy among HIV+ Pregnant Women in the
U.S. (Bivariate and Multivariable Analysis, n=172) *
RR (95% CI) p-value adjusted RR (95% CI)* p-value
One or more birth since HIV diagnosis 0.81 (0.75 – 0.87) <0.01 0.67 (0.47 – 0.94) 0.02
Provider-initiated discussion 0.85 (0.73 - 1.00) 0.05 1.01 (0.84-1.22) 0.91
Patient-initiated discussion 0.70 (0.59 – 0.83) <0.01 0.63 (0.46 – 0.77) <0.01
Saw medical provider in year prior to pregnancy 0.81 (0.72 - 0.92) <0.01 0.60 (0.46 - 0.77) <0.01
Known biological father 0.79 (0.73 – 0.86) <0.01 0.93 (0.78-1.11) 0.42
Mother's HIV status known to biological father 0.78 (0.71 – 0.86) <0.01 0.87 (0.73-1.03) 0.11
*
Reference groups not presented. The referent for Age was <29 years; for all other variables, the referent was “No” or “None”
**
Adjusted for age, race, and variables with a statistically significant (p<0.05) bivariate association (all listed in this table)
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